Home » Topics » Regulatory

Regulatory
RSS

AstraZeneca seeks approval for Nexium in NSAID-associated upper GI symptoms

April 3, 2003

Further analysis of Lescol LIPS results

April 2, 2003

FDA approves carvedilol for reducing risk of myocardial infarction

April 2, 2003

Emend approved by FDA for chemotherapy-induced nausea and vomiting

March 31, 2003

Label extension approved for Cozaar

March 31, 2003

CPMP recommends approval of Busulfex in Europe

March 27, 2003

Launch date set for Finacea

March 24, 2003

Photofrin approved in Canada for HGD associated with Barrett's esophagus

March 24, 2003

Lantus approved in E.U. for pediatric use

March 21, 2003

FDA approves expanded label for Betaseron; ABOVE trial explores increased dose and frequency

March 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...